Study of Subcutaneous and Intravenous ALXN1720 With and Without rHuPH20 in Healthy Subjects

NCT04920370 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ALXN1720 SC
DRUG: ALXN1720 IV
DRUG: rHuPH20
DRUG: Placebo SC
DRUG: Placebo IV

Sponsor

Alexion Pharmaceuticals, Inc.